Details of the Drug Reposition

General Information of This Drug (ID: DM7SMNJ)

• Drug Name: NKTR-255 (DM7SMNJ)

Information on Drug Reposition of This Drug

2 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Colorectal cancer	DISNH7P9	2B91.Z	Phase 1/2	[1]
Head and neck cancer	DISBPSQZ	2D42	Phase 1/2	[1]

References

• [1] ClinicalTrials.gov (NCT04616196) Study of NKTR 255 in Combination With Cetuximab in Solid Tumors. U.S. National Institutes of Health.